Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1988 Jun;85(11):3835–3839. doi: 10.1073/pnas.85.11.3835

Vincristine-resistant erythroleukemia cell line has marked increased sensitivity to hexamethylenebisacetamide-induced differentiation.

E Melloni 1, S Pontremoli 1, G Damiani 1, P Viotti 1, N Weich 1, R A Rifkind 1, P A Marks 1
PMCID: PMC280314  PMID: 3163801

Abstract

Hexamethylenebisacetamide (HMBA)-induced murine erythroleukemia (MEL) differentiation is a multistep process. Commitment is the capacity to express terminal cell division and characteristics of the differentiated phenotype even after the cells are removed from culture with inducer. Culture of MEL cell line 745A.DS19 (DS19) with HMBA causes commitment to terminal differentiation after a latent period of about 10-12 hr. Previous studies have shown that during this latent period, HMBA causes a number of metabolic changes, including modulation in expression of certain protooncogenes. We now report the development of a MEL cell line (designated V3.17) derived from DS19 that is resistant to vincristine and is (i) markedly more sensitive to HMBA, (ii) induced to commitment without a detectable latent period, and (iii) resistant to the effects of phorbol ester and dexamethasone, which are potent inhibitors of HMBA-mediated DS19 differentiation. We suggest that this V3.17 MEL cell line may express a factor that circumvents HMBA-mediated early events, which prepare the cells for commitment to terminal differentiation.

Full text

PDF
3835

Images in this article

3837Image
on p.3837

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein A., Hunt D. M., Crichley V., Mak T. W. Induction by ouabain of hemoglobin synthesis in cultured Friend erythroleukemic cells. Cell. 1976 Nov;9(3):375–381. doi: 10.1016/0092-8674(76)90082-9. [DOI] [PubMed] [Google Scholar]
  2. Bridges K., Levenson R., Housman D., Cantley L. Calcium regulates the commitment of murine erythroleukemia cells to terminal erythroid differentiation. J Cell Biol. 1981 Aug;90(2):542–544. doi: 10.1083/jcb.90.2.542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chen Z., Banks J., Rifkind R. A., Marks P. A. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process. Proc Natl Acad Sci U S A. 1982 Jan;79(2):471–475. doi: 10.1073/pnas.79.2.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Croop J. M., Guild B. C., Gros P., Housman D. E. Genetics of multidrug resistance: relationship of a cloned gene to the complete multidrug resistant phenotype. Cancer Res. 1987 Nov 15;47(22):5982–5988. [PubMed] [Google Scholar]
  5. Curtis P., Finnigan A. C., Rovera G. The beta major and beta minor globin nuclear transcripts of Friend erythroleukemia cells induced to differentiate in culture. J Biol Chem. 1980 Oct 10;255(19):8971–8974. [PubMed] [Google Scholar]
  6. Dano K. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim Biophys Acta. 1973 Oct 25;323(3):466–483. doi: 10.1016/0005-2736(73)90191-0. [DOI] [PubMed] [Google Scholar]
  7. Fibach E., Reuben R. C., Rifkind R. A., Marks P. A. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells. Cancer Res. 1977 Feb;37(2):440–444. [PubMed] [Google Scholar]
  8. Fojo A., Akiyama S., Gottesman M. M., Pastan I. Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. Cancer Res. 1985 Jul;45(7):3002–3007. [PubMed] [Google Scholar]
  9. Friend C., Scher W., Holland J. G., Sato T. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci U S A. 1971 Feb;68(2):378–382. doi: 10.1073/pnas.68.2.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gazitt Y., Deitch A. D., Marks P. A., Rifkind R. A. Cell volume changes in relation to the cell cycle of differentiating erythroleukemic cells. Exp Cell Res. 1978 Dec;117(2):413–420. doi: 10.1016/0014-4827(78)90154-4. [DOI] [PubMed] [Google Scholar]
  11. Gazitt Y., Reuben R. C., Deitch A. D., Marks P. A., Rifkind R. A. Changes in cyclic adenosine 3':5'-monophosphate levels during induction of differentiation in murine erythroleukemia cells. Cancer Res. 1978 Nov;38(11 Pt 1):3779–3783. [PubMed] [Google Scholar]
  12. Glisin V., Crkvenjakov R., Byus C. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry. 1974 Jun 4;13(12):2633–2637. doi: 10.1021/bi00709a025. [DOI] [PubMed] [Google Scholar]
  13. Gros P., Ben Neriah Y. B., Croop J. M., Housman D. E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature. 1986 Oct 23;323(6090):728–731. doi: 10.1038/323728a0. [DOI] [PubMed] [Google Scholar]
  14. Gusella J., Geller R., Clarke B., Weeks V., Housman D. Commitment to erythroid differentiation by friend erythroleukemia cells: a stochastic analysis. Cell. 1976 Oct;9(2):221–229. doi: 10.1016/0092-8674(76)90113-6. [DOI] [PubMed] [Google Scholar]
  15. Kaneko T., Nomura S., Oishi M. Early events leading to erythroid differentiation in mouse Friend cells revealed by cell fusion experiments. Cancer Res. 1984 May;44(5):1756–1760. [PubMed] [Google Scholar]
  16. Lachman H. M., Skoultchi A. I. Expression of c-myc changes during differentiation of mouse erythroleukaemia cells. Nature. 1984 Aug 16;310(5978):592–594. doi: 10.1038/310592a0. [DOI] [PubMed] [Google Scholar]
  17. Mager D., Bernstein A. The program of Friend cell erythroid differentiation: early changes in Na+/K+ ATPase function. J Supramol Struct. 1978;8(4):431–438. doi: 10.1002/jss.400080405. [DOI] [PubMed] [Google Scholar]
  18. Marks P. A., Rifkind R. A. Erythroleukemic differentiation. Annu Rev Biochem. 1978;47:419–448. doi: 10.1146/annurev.bi.47.070178.002223. [DOI] [PubMed] [Google Scholar]
  19. Marks P. A., Sheffery M., Rifkind R. A. Induction of transformed cells to terminal differentiation and the modulation of gene expression. Cancer Res. 1987 Feb 1;47(3):659–666. [PubMed] [Google Scholar]
  20. Melloni E., Pontremoli S., Michetti M., Sacco O., Cakiroglu A. G., Jackson J. F., Rifkind R. A., Marks P. A. Protein kinase C activity and hexamethylenebisacetamide-induced erythroleukemia cell differentiation. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5282–5286. doi: 10.1073/pnas.84.15.5282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Melton D. A., Krieg P. A., Rebagliati M. R., Maniatis T., Zinn K., Green M. R. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 1984 Sep 25;12(18):7035–7056. doi: 10.1093/nar/12.18.7035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nomura S., Yamagoe S., Kamiya T., Oishi M. An intracellular factor that induces erythroid differentiation in mouse erythroleukemia (Friend) cells. Cell. 1986 Feb 28;44(4):663–669. doi: 10.1016/0092-8674(86)90275-8. [DOI] [PubMed] [Google Scholar]
  23. Nudel U., Salmon J., Fibach E., Terada M., Rifkind R., Marks P. A., Bank A. Accumulation of alpha- and beta-globin messenger RNAs in mouse erythroleukemia cells. Cell. 1977 Oct;12(2):463–469. doi: 10.1016/0092-8674(77)90122-2. [DOI] [PubMed] [Google Scholar]
  24. Ohta Y., Tanaka M., Terada M., Miller O. J., Bank A., Marks P., Rifkind R. A. Erythroid cell differentiation: murine erythroleukemia cell variant with unique pattern of induction by polar compounds. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1232–1236. doi: 10.1073/pnas.73.4.1232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ramsay R. G., Ikeda K., Rifkind R. A., Marks P. A. Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6849–6853. doi: 10.1073/pnas.83.18.6849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Reuben R. C., Wife R. L., Breslow R., Rifkind R. A., Marks P. A. A new group of potent inducers of differentiation in murine erythroleukemia cells. Proc Natl Acad Sci U S A. 1976 Mar;73(3):862–866. doi: 10.1073/pnas.73.3.862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Roninson I. B., Chin J. E., Choi K. G., Gros P., Housman D. E., Fojo A., Shen D. W., Gottesman M. M., Pastan I. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4538–4542. doi: 10.1073/pnas.83.12.4538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sheffery M., Marks P. A., Rifkind R. A. Gene expression in murine erythroleukemia cells. Transcriptional control and chromatin structure of the alpha 1-globin gene. J Mol Biol. 1984 Feb 5;172(4):417–436. doi: 10.1016/s0022-2836(84)80015-7. [DOI] [PubMed] [Google Scholar]
  29. Skovsgaard T. Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells. Cancer Res. 1978 Dec;38(12):4722–4727. [PubMed] [Google Scholar]
  30. Terada M., Fried J., Nudel U., Rifkind R. A., Marks P. A. Transient inhibition of initiation of S-phase associated with dimethyl sulfoxide induction of murine erythroleukemia cells to erythroid differentiation. Proc Natl Acad Sci U S A. 1977 Jan;74(1):248–252. doi: 10.1073/pnas.74.1.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Terada M., Nudel U., Fibach E., Rifkind R. A., Marks P. A. Changes in DNA associated with induction of erythroid differentiation by dimethyl sulfoxide in murine erythroleukemia cells. Cancer Res. 1978 Mar;38(3):835–840. [PubMed] [Google Scholar]
  32. Todokoro K., Ikawa Y. Sequential expression of proto-oncogenes during a mouse erythroleukemia cell differentiation. Biochem Biophys Res Commun. 1986 Mar 28;135(3):1112–1118. doi: 10.1016/0006-291x(86)91043-0. [DOI] [PubMed] [Google Scholar]
  33. Tsiftsoglou A. S., Robinson S. H. Differentiation of leukemic cell lines: a review focusing on murine erythroleukemia and human HL-60 cells. Int J Cell Cloning. 1985 Nov;3(6):349–366. doi: 10.1002/stem.5530030602. [DOI] [PubMed] [Google Scholar]
  34. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res. 1982 Nov;42(11):4730–4733. [PubMed] [Google Scholar]
  35. Ullrich A., Shine J., Chirgwin J., Pictet R., Tischer E., Rutter W. J., Goodman H. M. Rat insulin genes: construction of plasmids containing the coding sequences. Science. 1977 Jun 17;196(4296):1313–1319. doi: 10.1126/science.325648. [DOI] [PubMed] [Google Scholar]
  36. Van der Bliek A. M., Van der Velde-Koerts T., Ling V., Borst P. Overexpression and amplification of five genes in a multidrug-resistant Chinese hamster ovary cell line. Mol Cell Biol. 1986 May;6(5):1671–1678. doi: 10.1128/mcb.6.5.1671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Watanabe T., Nomura S., Oishi M. Induction of erythroid differentiation by cytoplast fusion in mouse erythroleukemia (Friend) cells. Exp Cell Res. 1985 Jul;159(1):224–234. doi: 10.1016/s0014-4827(85)80051-3. [DOI] [PubMed] [Google Scholar]
  38. Weich N., Marks P. A., Rifkind R. A. Regulation of murine alpha-, beta major-, and beta minor-globin gene expression. Biochem Biophys Res Commun. 1988 Jan 15;150(1):204–211. doi: 10.1016/0006-291x(88)90506-2. [DOI] [PubMed] [Google Scholar]
  39. Yamasaki H., Fibach E., Nudel U., Weinstein I. B., Rifkind R. A., Marks P. A. Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3451–3455. doi: 10.1073/pnas.74.8.3451. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES